Cefiderocol for prosthetic joint infection: a case report
Treatment of Stenotrophonomas maltophilia infections is difficult due to its predilection to form biofilms and susceptibility to a limited number of antibiotics. We report a case of S. maltophilia -associated periprosthetic joint infection successfully treated with a combination of the novel therape...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2023-05-01
|
| Series: | Therapeutic Advances in Infectious Disease |
| Online Access: | https://doi.org/10.1177/20499361231174292 |
| _version_ | 1797822395081293824 |
|---|---|
| author | MaKenzie M. Chambers Christina J. Gutowski Katherine Doktor |
| author_facet | MaKenzie M. Chambers Christina J. Gutowski Katherine Doktor |
| author_sort | MaKenzie M. Chambers |
| collection | DOAJ |
| description | Treatment of Stenotrophonomas maltophilia infections is difficult due to its predilection to form biofilms and susceptibility to a limited number of antibiotics. We report a case of S. maltophilia -associated periprosthetic joint infection successfully treated with a combination of the novel therapeutic agent, cefiderocol, and trimethoprim-sulfamethoxazole after debridement and implant retention. |
| first_indexed | 2024-03-13T10:07:23Z |
| format | Article |
| id | doaj.art-5780a9d4c99d460c968a24532d5d060b |
| institution | Directory Open Access Journal |
| issn | 2049-937X |
| language | English |
| last_indexed | 2024-03-13T10:07:23Z |
| publishDate | 2023-05-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Therapeutic Advances in Infectious Disease |
| spelling | doaj.art-5780a9d4c99d460c968a24532d5d060b2023-05-22T09:03:34ZengSAGE PublishingTherapeutic Advances in Infectious Disease2049-937X2023-05-011010.1177/20499361231174292Cefiderocol for prosthetic joint infection: a case reportMaKenzie M. ChambersChristina J. GutowskiKatherine DoktorTreatment of Stenotrophonomas maltophilia infections is difficult due to its predilection to form biofilms and susceptibility to a limited number of antibiotics. We report a case of S. maltophilia -associated periprosthetic joint infection successfully treated with a combination of the novel therapeutic agent, cefiderocol, and trimethoprim-sulfamethoxazole after debridement and implant retention.https://doi.org/10.1177/20499361231174292 |
| spellingShingle | MaKenzie M. Chambers Christina J. Gutowski Katherine Doktor Cefiderocol for prosthetic joint infection: a case report Therapeutic Advances in Infectious Disease |
| title | Cefiderocol for prosthetic joint infection: a case report |
| title_full | Cefiderocol for prosthetic joint infection: a case report |
| title_fullStr | Cefiderocol for prosthetic joint infection: a case report |
| title_full_unstemmed | Cefiderocol for prosthetic joint infection: a case report |
| title_short | Cefiderocol for prosthetic joint infection: a case report |
| title_sort | cefiderocol for prosthetic joint infection a case report |
| url | https://doi.org/10.1177/20499361231174292 |
| work_keys_str_mv | AT makenziemchambers cefiderocolforprostheticjointinfectionacasereport AT christinajgutowski cefiderocolforprostheticjointinfectionacasereport AT katherinedoktor cefiderocolforprostheticjointinfectionacasereport |